Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting
enzyme 2 (ACE2) 1 , could represent a new chemoprophylactic approach for …

There is a rapidly expanding literature on the in vitro antiviral activity of drugs that may be
repurposed for therapy or chemoprophylaxis against severe acute respiratory syndrome‐…

Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been
declared a global pandemic and urgent treatment and prevention strategies are needed. …

Nanomedicine strategies have produced many commercial products. However, no orally
dosed HIV nanomedicines are available clinically to patients. Although nanosuspensions of …

The cyclic hexapeptide, cyclo (Pro-Phe-D-Trp-Lys-Thr-Phe), I, has been shown to have the
biological properties of somatostatin. We now report structure-activity studies which optimize …

Pharmaceutical excipients are no longer considered inert and have been shown to influence
the activity of metabolic enzymes and transporters, resulting in altered pharmacokinetics of …

Background Cabotegravir and rilpivirine are 2 long-acting (LA) antiretrovirals that can be
administered intramuscularly; their interaction with rifampicin, a first-line antituberculosis agent, …

Introduction: Nano-scale formulations are being developed to improve the delivery of orally
administered medicines, and the interactions between nanoformulations and the …

The increasing global prevalence of human immunodeficiency virus (HIV) is estimated at
36.7 million people currently infected. Lifelong antiretroviral (ARV) drug combination dosing …

Adequate concentrations of efavirenz in the central nervous system (CNS) are necessary to
suppress viral replication, but high concentrations may increase the likelihood of CNS …